These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 28109332)

  • 1. Structural Characteristics of α-Synuclein Oligomers.
    Cremades N; Chen SW; Dobson CM
    Int Rev Cell Mol Biol; 2017; 329():79-143. PubMed ID: 28109332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of α-Synuclein Amyloid Assemblies for Toxicity Experiments.
    Chen SW; Cremades N
    Methods Mol Biol; 2018; 1779():45-60. PubMed ID: 29886526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural characterization of toxic oligomers that are kinetically trapped during α-synuclein fibril formation.
    Chen SW; Drakulic S; Deas E; Ouberai M; Aprile FA; Arranz R; Ness S; Roodveldt C; Guilliams T; De-Genst EJ; Klenerman D; Wood NW; Knowles TP; Alfonso C; Rivas G; Abramov AY; Valpuesta JM; Dobson CM; Cremades N
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E1994-2003. PubMed ID: 25855634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insights into amyloid oligomers of the Parkinson disease-related protein α-synuclein.
    Gallea JI; Celej MS
    J Biol Chem; 2014 Sep; 289(39):26733-26742. PubMed ID: 25143382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures behind the amyloid aggregation of α-synuclein: an NMR based approach.
    Orcellet ML; Fernández CO
    Curr Protein Pept Sci; 2011 May; 12(3):188-204. PubMed ID: 21348834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of stable α-synuclein oligomers in the molecular events underlying amyloid formation.
    Lorenzen N; Nielsen SB; Buell AK; Kaspersen JD; Arosio P; Vad BS; Paslawski W; Christiansen G; Valnickova-Hansen Z; Andreasen M; Enghild JJ; Pedersen JS; Dobson CM; Knowles TP; Otzen DE
    J Am Chem Soc; 2014 Mar; 136(10):3859-68. PubMed ID: 24527756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural remodeling during amyloidogenesis of physiological Nα-acetylated α-synuclein.
    Gallea JI; Sarroukh R; Yunes-Quartino P; Ruysschaert JM; Raussens V; Celej MS
    Biochim Biophys Acta; 2016 May; 1864(5):501-10. PubMed ID: 26845568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A glimpse into the structural properties of α-synuclein oligomers.
    Santos J; Pallarès I; Ventura S
    Biofactors; 2024; 50(3):439-449. PubMed ID: 38063360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards multiparametric fluorescent imaging of amyloid formation: studies of a YFP model of alpha-synuclein aggregation.
    van Ham TJ; Esposito A; Kumita JR; Hsu ST; Kaminski Schierle GS; Kaminski CF; Dobson CM; Nollen EA; Bertoncini CW
    J Mol Biol; 2010 Jan; 395(3):627-42. PubMed ID: 19891973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heme Stabilization of α-Synuclein Oligomers during Amyloid Fibril Formation.
    Hayden EY; Kaur P; Williams TL; Matsui H; Yeh SR; Rousseau DL
    Biochemistry; 2015 Aug; 54(30):4599-610. PubMed ID: 26161848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplicity of α-Synuclein Aggregated Species and Their Possible Roles in Disease.
    Gracia P; Camino JD; Volpicelli-Daley L; Cremades N
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution.
    Li X; Dong C; Hoffmann M; Garen CR; Cortez LM; Petersen NO; Woodside MT
    Sci Rep; 2019 Feb; 9(1):1734. PubMed ID: 30741954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural, morphological, and functional diversity of amyloid oligomers.
    Breydo L; Uversky VN
    FEBS Lett; 2015 Sep; 589(19 Pt A):2640-8. PubMed ID: 26188543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seeking a mechanism for the toxicity of oligomeric α-synuclein.
    Roberts HL; Brown DR
    Biomolecules; 2015 Mar; 5(2):282-305. PubMed ID: 25816357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic prefibrillar α-synuclein amyloid oligomers adopt a distinctive antiparallel β-sheet structure.
    Celej MS; Sarroukh R; Goormaghtigh E; Fidelio GD; Ruysschaert JM; Raussens V
    Biochem J; 2012 May; 443(3):719-26. PubMed ID: 22316405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Pairs of Toxic and Nontoxic Misfolded Protein Oligomers Elucidates the Structural Determinants of Oligomer Toxicity in Protein Misfolding Diseases.
    Limbocker R; Cremades N; Cascella R; Tessier PM; Vendruscolo M; Chiti F
    Acc Chem Res; 2023 Jun; 56(12):1395-1405. PubMed ID: 37071750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity.
    Xu CK; Castellana-Cruz M; Chen SW; Du Z; Meisl G; Levin A; Mannini B; Itzhaki LS; Knowles TPJ; Dobson CM; Cremades N; Kumita JR
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro study of α-synuclein protofibrils by cryo-EM suggests a Cu(2+)-dependent aggregation pathway.
    Zhang H; Griggs A; Rochet JC; Stanciu LA
    Biophys J; 2013 Jun; 104(12):2706-13. PubMed ID: 23790379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effects of biomimetically designed peptides on α-synuclein aggregation.
    Rezaeian N; Shirvanizadeh N; Mohammadi S; Nikkhah M; Arab SS
    Arch Biochem Biophys; 2017 Nov; 634():96-106. PubMed ID: 28965745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.